Abnormal expression of CD19 can be observed in many hematologic malignancies associated with B cells, contributing to tumorigenesis, besides, expression of CD19 is restricted to malignant and normal B-lineage cells [26–28]. The gene discussed is CD19; the disease is hematologic disorder.